Two new divisional directors have joined the UK-Ireland business of Leo Pharma.
Mike Williams, most recently at Roche, joins the company as dermatology director for UK and Ireland, while Barbara Reilly moves from her former role as country manager for Leo Pharma in Ireland to head the company’s thrombosis division in the UK and Ireland.
Williams (pictured right) spent just over a year at Roche, initially serving as business unit director for the company’s cardio-metabolism unit before being appointed Western Europe market access leader.
He has served at a number of other large pharma companies, including time as senior product manager at Merck & Co, sales manager at Pfizer in the UK and business manager at AstraZeneca.
“It is an exciting time to join Leo following the refocus of the organisation last October on building a global patient centric organisation,” said Mike Williams.
Reilly (pictured left) was country manager of Leo Pharma in Ireland for just over two years before the company integrated its UK and Ireland business.
Prior to her time in Ireland, she was sales and marketing director for Leo.
“I am relishing the opportunity that lies ahead to lead the thrombosis team in an increasingly challenging and evolving market while utilising all our experiences to support the patients and stakeholders in both market places,” said Reilly.